Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:33 PM
Ignite Modification Date:
2025-12-24 @ 5:33 PM
NCT ID:
NCT02631668
Eligibility Criteria:
Inclusion Criteria:
* Hemoglobin (Hb) \< 120 g/L in men and Hb \< 110 g/L in women; Mean Corpuscular Volume(MCV) \< 80 fl, Mean Corpuscular Hemoglobin(MCH) \< 27 pg, and Mean Corpuscular Hemoglobin Concentration(MCHC) \< 0.32; the blood biochemical examination: serum ferritin \< 12 g/L, serum iron \< 8.95 mol/L, transferrin saturation \<15%, and total iron binding capacity\>64.44 mol/L; with a history of Menorrhagia, monophagia or eating disorders; Willing to sign a Informed consent form.
Exclusion Criteria:
* Pregnant women; drug allergy; the patients with serious gastrorrhagia, other peptic ulcers, active bleeding, hepatic insufficiency, heart disease or renal insufficiency; those patients can't tolerate the medicine orally, or participate in other clinical study, or refuse to sign a Informed consent Form.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT02631668
Study Brief:
Protocol Section:
NCT02631668